The impact of Recovery Colleges on mental health staff, services and society.


Journal

Epidemiology and psychiatric sciences
ISSN: 2045-7979
Titre abrégé: Epidemiol Psychiatr Sci
Pays: England
ID NLM: 101561091

Informations de publication

Date de publication:
Oct 2019
Historique:
pubmed: 24 10 2018
medline: 27 9 2019
entrez: 24 10 2018
Statut: ppublish

Résumé

Recovery Colleges are opening internationally. The evaluation focus has been on outcomes for Recovery College students who use mental health services. However, benefits may also arise for: staff who attend or co-deliver courses; the mental health and social care service hosting the Recovery College; and wider society. A theory-based change model characterising how Recovery Colleges impact at these higher levels is needed for formal evaluation of their impact, and to inform future Recovery College development. The aim of this study was to develop a stratified theory identifying candidate mechanisms of action and outcomes (impact) for Recovery Colleges at staff, services and societal levels. Inductive thematic analysis of 44 publications identified in a systematised review was supplemented by collaborative analysis involving a lived experience advisory panel to develop a preliminary theoretical framework. This was refined through semi-structured interviews with 33 Recovery College stakeholders (service user students, peer/non-peer trainers, managers, community partners, clinicians) in three sites in England. Candidate mechanisms of action and outcomes were identified at staff, services and societal levels. At the staff level, experiencing new relationships may change attitudes and associated professional practice. Identified outcomes for staff included: experiencing and valuing co-production; changed perceptions of service users; and increased passion and job motivation. At the services level, Recovery Colleges often develop somewhat separately from their host system, reducing the reach of the college into the host organisation but allowing development of an alternative culture giving experiential learning opportunities to staff around co-production and the role of a peer workforce. At the societal level, partnering with community-based agencies gave other members of the public opportunities for learning alongside people with mental health problems and enabled community agencies to work with people they might not have otherwise. Recovery Colleges also gave opportunities to beneficially impact on community attitudes. This study is the first to characterise the mechanisms of action and impact of Recovery Colleges on mental health staff, mental health and social care services, and wider society. The findings suggest that a certain distance is needed in the relationship between the Recovery College and its host organisation if a genuine cultural alternative is to be created. Different strategies are needed depending on what level of impact is intended, and this study can inform decision-making about mechanisms to prioritise. Future research into Recovery Colleges should include contextual evaluation of these higher level impacts, and investigate effectiveness and harms.

Identifiants

pubmed: 30348246
pii: S204579601800063X
doi: 10.1017/S204579601800063X
pmc: PMC6998922
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

481-488

Subventions

Organisme : Department of Health
ID : RP-DG-0615-10008
Pays : United Kingdom

Références

Epidemiol Psychiatr Sci. 2019 Aug;28(4):408-417
pubmed: 29199920
Epidemiol Psychiatr Sci. 2014 Jun;23(2):155-65
pubmed: 23683403
Psychiatr Serv. 2018 Dec 1;69(12):1222-1229
pubmed: 30220242
Epidemiol Psychiatr Sci. 2018 Oct;27(5):413-414
pubmed: 29644948
Epidemiol Psychiatr Sci. 2017 Oct;26(5):517-525
pubmed: 27466083
BMC Psychiatry. 2018 Jun 28;18(1):213
pubmed: 29954373
Am Psychol. 2013 Oct;68(7):527-42
pubmed: 24128316
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Can J Psychiatry. 2019 Jun;64(6):405-414
pubmed: 30595039
World Psychiatry. 2014 Feb;13(1):12-20
pubmed: 24497237
Psychiatr Rehabil J. 2016 Jun;39(2):187-190
pubmed: 27148854
Epidemiol Psychiatr Sci. 2015 Oct;24(5):435-45
pubmed: 24992284
World Psychiatry. 2017 Jun;16(2):146-153
pubmed: 28498575
J Ment Health. 2018 Aug;27(4):359-366
pubmed: 29275749
Lancet. 2016 Mar 12;387(10023):1123-1132
pubmed: 26410341
Acta Psychiatr Scand. 2016 Aug;134 Suppl 446:14-22
pubmed: 27426642
Epidemiol Psychiatr Sci. 2016 Oct;25(5):410-416
pubmed: 27118346
Lancet Psychiatry. 2014 Nov;1(6):467-82
pubmed: 26361202
Ann Intern Med. 2004 Nov 16;141(10):781-8
pubmed: 15545678

Auteurs

A Crowther (A)

Sussex Partnership NHS Foundation Trust, Worthing, West Sussex, UK.

A Taylor (A)

King's College London, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, London, UK.

R Toney (R)

School of Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham, Nottinghamshire, UK.

S Meddings (S)

Sussex Partnership NHS Foundation Trust, Worthing, West Sussex, UK.

T Whale (T)

RECOLLECT Lived Experience Advisory Panel, Nottingham, UK.

H Jennings (H)

Department of Occupational Therapy, School of Health Sciences, York St. John University, York, UK.

K Pollock (K)

School of Health Sciences, University of Nottingham, Nottingham, UK.

P Bates (P)

Peter Bates Associates Ltd, Nottingham, UK.

C Henderson (C)

King's College London, Health Service and Population Research Department, Institute of Psychiatry, Psychology and Neuroscience, London, UK.
Health Service and Population Research Department, King's College London, Institute of Psychiatry, Psychology and Neuroscience and South London and Maudsley NHS Foundation Trust, London, UK.

J Waring (J)

Nottingham University Business School, University of Nottingham, Nottingham, UK.

M Slade (M)

School of Health Sciences, Institute of Mental Health, University of Nottingham, Nottingham, Nottinghamshire, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH